BSE filing, NSE: KOKUYOCMLN. Summary written from the filing by ALFA Finder's alert engine.
Kokuyo Camlin Ltd: key numbers
- Share price
- ₹71.17
- Market cap
- ₹713.9 Cr
- Revenue (annual)
- ₹806.0 Cr
- Net profit (annual)
- ₹24.79 Cr
- P/E (TTM)
- 32.4×Sector 43.1×
- Promoter holding
- 74.99%+0.00% QoQ
- FII holding
- 0.06%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kokuyo Camlin Ltd
All →Kokuyo Camlin Board Meeting Date
Kokuyo Camlin will hold a board meeting on 4 November 2026 to consider unaudited Q2 and half-year September 2026 results. The trading window stays closed until 48 hours after the results are declared.
Kokuyo Camlin Other Announcement
The company filed its quarterly shareholding pattern for the period ended September 30, 2026. It includes an explanatory note regarding a transmission of shares.
Kokuyo Camlin Legal & Regulatory
Kokuyo Camlin received a notice from the Registrar of Companies under Section 206(1) of the Companies Act regarding historical records, employee fraud, and inventory discrepancies.
- From
- Registrar of Companies (ROC), Rajasthan
Kokuyo Camlin Legal & Regulatory
Kokuyo Camlin received a GST demand order totaling Rs.7.80 Lakhs, including tax, interest, and penalty. The company intends to file an appeal.
- Value
- ₹0.08 Cr
- From
- Office of the Assistant Commissioner
Kokuyo Camlin Legal & Regulatory
Kokuyo Camlin received a GST demand order from the Assistant Commissioner, Chennai, totaling Rs. 1.12 Crore including interest and penalty. The company plans to appeal.
- Value
- ₹1.12 Cr
Kokuyo Camlin Annual General Meeting
Kokuyo Camlin held its 79th Annual General Meeting on August 6, 2026. The company transacted ordinary and special business items during the meeting.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.